Treatment of Opioid Dependency / Addiction by Subutex (Buprenorphine) Shown Greater Extent Than Clonidine (Catapres)

Treatment of Opioid Dependency / Addiction by Subutex (Buprenorphine) Shown Grea

Physical dependence on a substance is defined by the appearance of characteristic withdrawal symptoms when the substance or behavior is suddenly discontinued. While opioids, benzodiazepines, barbiturates, alcohol and nicotine are all well known for their ability to induce physical dependence.So, while physical dependency can be a major factor in the psychology of addiction and most often becomes a primary motivator in the continuation of an addiction, the primary attribute of an addictive substance is usually its ability to induce pleasure and its facility in becoming routinely used. The user is likely fulfilling his/her physical addiction and, therefore, is achieving pleasurable feelings relative to his/her previous state of physical withdrawal.

You have a problem if you keep craving and using opioids even if it's causing trouble for you. The trouble may be with your health, with money, with work or school, or with your relationships with family or friends. Your friends and family may be aware you're having a problem before you realize it, because they see changes in your behavior. Opioid drugs include :opium ,codeine ,fentanyl ,heroin ,hydrocodone ,methadone ,morphine ,oxycodone,paregoric ,sufentanil .

Breaking a drug addiction is difficult, but not impossible. Support from your doctor, family, friends and others who have a drug addiction, as well as inpatient or outpatient drug addiction treatment, may help you beat your drug dependence.Medicine recommends treatment for people with opioid dependency based on patient placement criteria which attempt to match levels of care according to clinical assessments in six areas, including:

Adolescents addicted to opioids responded better to buprenorphine than clonidine in a clinical trial in which all patients also received behavioral therapy. In the NIDA-supported comparison trial at the University of Vermont, adolescents who received buprenorphine attended more scheduled counseling sessions than peers who received clonidine and had higher rates of successful induction to a relapse prevention regimen of naltrexone.

Naltrexone is a medication that blocks the effects of drugs known as opioids (a class that includes morphine, heroin or codeine). It competes with these drugs for opioid receptors in the brain. It was originally used to treat dependence on opioid drugs but has recently been approved by the FDA as treatment for alcoholism. In clinical trials evaluating the effectiveness of naltrexone, patients who received naltrexone were twice as successful in remaining abstinent and in avoiding relapse as patients who received placebo-an inactive pill. The study, led by Dr. Lisa Marsch, is the first published randomized controlled study of treatments for adolescents addicted to opioids.

"Heroin abuse among American teens has doubled over the past decade, and abuse of prescription opioids such as OxyContin and Vicodin has increased even more," says Dr. Marsch. "In light of those figures, it's important to have a scientific basis for selecting treatments for opioid-dependent teens. We know from previous research and clinical experience that buprenorphine and, to a lesser extent, clonidine are among the medications that have been shown to be effective for treating opioid-addicted adults, but we haven't known how helpful they can be for adolescents."

BUPRENORPHINE DETOXIFICATION SETS STAGE FOR RECOVERY : Opioid-addicted adolescents who entered a detoxification program with buprenorphine were more likely than others receiving clonidine to maintain abstinence throughout a 28-day detoxification program and more likely to begin treatment with naltrexone after detoxification.

Dr. Marsch and colleagues enrolled 36 opioid-addicted adolescents, aged 13 to 18, in a 28-day outpatient treatment program. Half the participants (9 male, 9 female) received buprenorphine in tablet form, the rest (5 male, 13 female) clonidine via transdermal patch; each patient also was given a placebo resembling the other treatment. Medication dosages varied depending on each participant's weight and the amount of drug he or she reported abusing before beginning treatment; dosages of buprenorphine were in the low to moderate range of those typically given to opioid-addicted adults.

All participants also received behavioral therapy based on the Community Reinforcement Approach: three 1-hour sessions each week of counseling on methods to minimize involvement in situations that might lead to drug-taking, training to help recognize and control urges to abuse opioids, and encouragement to recruit family members as allies for abstinence. Participants earned vouchers worth $2.50 for the first opioid-negative urine sample, plus an additional $1.25 for each subsequent one, and a $10 bonus for each set of three consecutive negative samples. Continuous abstinence could earn participants $152.50 in vouchers redeemable for rewards such as ski passes, CDs, gym passes, and clothing.

Buprenorphine and clonidine both supported high rates of abstinence. Among participants who completed treatment, rates were 78 percent and 81 percent, respectively, confirmed by urine samples provided at the thrice-weekly sessions. However, nearly twice as many buprenorphine as clonidine recipients completed the 4-week treatment (72 percent compared with 39 percent). "The high rate of retention in the buprenorphine group is particularly noteworthy," Dr. Marsch says, "because long-term success in recovery is directly related to the amount of time patients spend in treatment." And, she adds, the willingness of most patients who received buprenorphine to continue treatment with naltrexone following completion of the 28-day program is similarly encouraging. Sixty-one percent of the buprenorphine group, but only 5 percent of those who received clonidine accepted naltrexone.

"Dr. Marsch's research is an important first step in systematically studying adolescents who are addicted to opioids," says Dr. Ivan Montoya of NIDA's Division of Pharmacotherapies and Medical Consequences of Drug Abuse. "We know that there are differences in the patterns of opiate abuse and addiction in young people compared with adults. We need dedicated studies like this one to understand how teens are affected by opiate drugs and how best to treat them."

The next step in Dr. Marsch's research will involve a larger sample of young opioid abusers. "We want to evaluate buprenorphine's effectiveness if treatment is extended to 2 months rather than 28 days," she says. "We will also examine the most effective doses and dosing regimens for various subgroups of young patients."

Comments

Post new comment

Similar

  • Depression, Mania, Suicidal Tendencies During Pregnancy - Nearly all women experience some degree of "morning sickness" -- nausea and vomiting during pregnancy, particularly during the first trimester. The cause of nausea and vomiting during pregnancy is believed to be rapidly rising serum levels of a hormone called HCG (human chorionic gonadotropin) secreted by the fetus. Increased estrogen levels have also been implicated.
  • Herbal Shisha have Same Harmful Effect; don’t Confuse for Herbal - The popularity of hookah, also known as shisha and narghile, runs against the anti-tobacco trend, partly because it appeals to teens and young adults. Water pipes also are exempted from some smoke-free laws and enjoy a mystique of being a more cultural and safer alternative to cigarettes. But the truth is every risk of cigarette smoking is also associated with water pipes.
  • Mechanism of Action of Schizophrenia for More Targeted Treatment - Schizophrenia remains an enigma that has fascinated the foremost minds of psychiatry and neuroscience for more than a hundred years.
  • Nap During the Day is Beneficial for Health - The contrast between exposure to daylight and night-time darkness is thought to adjust and maintain this clock, which helps makes sure the body is working as effectively as possible at times of day when maximum alertness is required. Most adults need about 7 to 8 hours of sleep each night. You know you're getting enough sleep if you don't feel sleepy during the day.
  • Hip Replacement Surgery Overview - Hip Resurface Center - total Hip Replacement - Birmingham Hip Resurfacing - What is Hip Resurfacing?
  • Role of 5-htp; is it Safe as Supplement? - One of the raw materials that your body needs to make serotonin is a chemical called 5-HTP, which is short for 5-hydroxytryptophan. 5-HTP is a naturally-occurring amino acid, a precursor to the neurotransmitter serotonin and an intermediate in tryptophan metabolism.
  • The Discovery of the Peptide may Inhibit Influenza Viruses - Flu rapidly spreads around the world in seasonal epidemics, killing millions of people in pandemic years and hundreds of thousands in nonpandemic years. It creates health care costs and lost productivity.